Search research articles
Contact Us
Filters
Showing results (61-70 of 200) with videos related to
Page
of 20
Sort By:
Anticancer Research
|
May 29, 2017
MEK162 Enhances Antitumor Activity of 5-Fluorouracil and Trifluridine in KRAS-mutated Human Colorectal Cancer Cell Lines
Jun Gong, Yuan Chen, Lixin Yang, et al.
Journal of Gastrointestinal Oncology
|
July 13, 2018
Immune profiling of microsatellite instability-high and polymerase ε (<i>POLE</i>)-mutated metastatic colorectal tumors identifies predictors of response to anti-PD-1 therapy
Chongkai Wang, Jun Gong, Travis Y Tu, et al.
Clinical Colorectal Cancer
|
January 13, 2021
MAP2K1 Mutations in Advanced Colorectal Cancer Predict Poor Response to Anti-EGFR Therapy and to Vertical Targeting of MAPK Pathway
Jeremy Chuang, Chongkai Wang, Yuming Guo, et al.
JAMA Oncology
|
March 9, 2023
Regorafenib, Ipilimumab, and Nivolumab for Patients With Microsatellite Stable Colorectal Cancer and Disease Progression With Prior Chemotherapy: A Phase 1 Nonrandomized Clinical Trial
Marwan Fakih, Jaideep Sandhu, Dean Lim, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 19, 2023
Immunotherapy response in microsatellite stable metastatic colorectal cancer is influenced by site of metastases
Marwan Fakih, Chongkai Wang, Jaideep Sandhu, et al.
Oncology
|
February 1, 2006
Chemotherapy-induced carcinoembryonic antigen surge in patients with metastatic colorectal cancer
Sikander Ailawadhi, Annette Sunga, Ashwani Rajput, et al.
Anticancer Research
|
August 5, 2006
Vitamin D compounds: clinical development as cancer therapy and prevention agents
Donald L Trump, Josephia Muindi, Marwan Fakih, et al.
JAMA Network Open
|
August 9, 2021
Clinical Response to Immunotherapy Targeting Programmed Cell Death Receptor 1/Programmed Cell Death Ligand 1 in Patients With Treatment-Resistant Microsatellite Stable Colorectal Cancer With and Without Liver Metastases
Chongkai Wang, Jaideep Sandhu, Ching Ouyang, et al.
Journal of Gastrointestinal Oncology
|
July 20, 2012
KRAS status and clinical outcome in metastatic colorectal cancer patients treated with first-line FOLFOX chemotherapy
Neelesh Sharma, Maher Saifo, Ila R Tamaskar, et al.
Cancer Treatment and Research Communications
|
May 23, 2021
Chemotherapy-induced early transient increase and surge of CA 19-9 level in patients with pancreatic Adenocarcinoma<sup>✰</sup>
Viet H Le, Jan Franko, Benjamin I Paz, et al.
Page
of 20
Search research articles
Search
Showing results (61-70 of 200) with videos related to
Sort By:
Page
of 20
Anticancer Research
|
May 29, 2017
MEK162 Enhances Antitumor Activity of 5-Fluorouracil and Trifluridine in KRAS-mutated Human Colorectal Cancer Cell Lines
Jun Gong, Yuan Chen, Lixin Yang, et al.
Journal of Gastrointestinal Oncology
|
July 13, 2018
Immune profiling of microsatellite instability-high and polymerase ε (<i>POLE</i>)-mutated metastatic colorectal tumors identifies predictors of response to anti-PD-1 therapy
Chongkai Wang, Jun Gong, Travis Y Tu, et al.
Clinical Colorectal Cancer
|
January 13, 2021
MAP2K1 Mutations in Advanced Colorectal Cancer Predict Poor Response to Anti-EGFR Therapy and to Vertical Targeting of MAPK Pathway
Jeremy Chuang, Chongkai Wang, Yuming Guo, et al.
JAMA Oncology
|
March 9, 2023
Regorafenib, Ipilimumab, and Nivolumab for Patients With Microsatellite Stable Colorectal Cancer and Disease Progression With Prior Chemotherapy: A Phase 1 Nonrandomized Clinical Trial
Marwan Fakih, Jaideep Sandhu, Dean Lim, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 19, 2023
Immunotherapy response in microsatellite stable metastatic colorectal cancer is influenced by site of metastases
Marwan Fakih, Chongkai Wang, Jaideep Sandhu, et al.
Oncology
|
February 1, 2006
Chemotherapy-induced carcinoembryonic antigen surge in patients with metastatic colorectal cancer
Sikander Ailawadhi, Annette Sunga, Ashwani Rajput, et al.
Anticancer Research
|
August 5, 2006
Vitamin D compounds: clinical development as cancer therapy and prevention agents
Donald L Trump, Josephia Muindi, Marwan Fakih, et al.
JAMA Network Open
|
August 9, 2021
Clinical Response to Immunotherapy Targeting Programmed Cell Death Receptor 1/Programmed Cell Death Ligand 1 in Patients With Treatment-Resistant Microsatellite Stable Colorectal Cancer With and Without Liver Metastases
Chongkai Wang, Jaideep Sandhu, Ching Ouyang, et al.
Journal of Gastrointestinal Oncology
|
July 20, 2012
KRAS status and clinical outcome in metastatic colorectal cancer patients treated with first-line FOLFOX chemotherapy
Neelesh Sharma, Maher Saifo, Ila R Tamaskar, et al.
Cancer Treatment and Research Communications
|
May 23, 2021
Chemotherapy-induced early transient increase and surge of CA 19-9 level in patients with pancreatic Adenocarcinoma<sup>✰</sup>
Viet H Le, Jan Franko, Benjamin I Paz, et al.
Page
of 20